This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

NewLink Genetics Corp (NLNK)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 61.29M 20.25M 39.49M
Receivables 1.66M 738.00K 399.00K
Inventories 0.00 0.00 0.00
Other Current Assets 0.00 907.00K 0.00
Total Current Assets 63.97M 23.39M 42.79M
Property, Plant & Equipment, Gross 10.44M 9.02M 8.50M
Accumulated Depreciation & Depletion 3.86M 2.98M 2.91M
Property, Plant & Equipment, Net 6.59M 6.04M 5.59M
Intangibles 0.00 0.00 0.00
Other Non-Current Assets 0.00 0.00 0.00
Total Non-Current Assets 6.59M 6.04M 5.59M
Liabilities & Shareholder Equity
Total Assets 70.56M 29.43M 48.38M
Accounts Payable 612.00K 972.00K 1.67M
Short Term Debt 189.00K 204.00K 214.00K
Other Current Liabilities 130.00K 0.00 0.00
Total Current Liabilities 3.88M 2.92M 10.66M
Long Term Debt 987.00K 1.14M 848.00K
Deferred Income Taxes 0.00 0.00 0.00
Other Non-Current Liabilities 7.32M 1.40M 0.00
Minority Interest 0.00 0.00 -1.00K
Total Non-Current Liabilities 8.35M 8.58M 942.00K
Total Liabilities 12.23M 11.50M 11.61M
Preferred Stock Equity 0.00 0.00 0.00
Common Stock Equity 58.33M 17.93M 36.77M
Common Par 266.00K 210.00K 206.00K
Additional Paid In Capital 194.04M 122.51M 118.04M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings -135.98M -104.80M -81.48M
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00
Total Capitalization 59.31M 19.07M 37.62M
Total Equity 58.33M 17.93M 36.77M
Total Liabilities & Stock Equity 70.56M 29.43M 48.38M
Total Common Shares Outstanding 26.57M 20.99M 20.59M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 25.28M 20.78M 6.06M
Diluted Weighted Shares Outstanding 25.28M 20.78M 6.06M
Number of Employees 104 94 77
Number of Part-Time Employees 0 0 0
NLNK News

NLNK NewLink Genetics Corp

Analysts Ratings for NLNK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 4
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET NLNK ANALYST REPORT

Brokerage Partners

NLNK Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs